Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
2018 · JAMA · 1,047 citations
https://doi.org/10.1001/jama.2018.18269
J
Jyothis T. George
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
240
Papers
10.5K
Citations
51
h-index
103
i10-index
Jyothis T. George is an academic researcher from Amgen (United States). The author has contributed to research in topics: Diabetes Treatment and Management & Pancreatic function and diabetes & Diabetes Management and Research. The author has an h-index of 51, co-authored 204 publications.
ORCID: 0000-0002-5299-775XPapers by this author
worksThe kisspeptin-GnRH pathway in human reproductive health and disease
2014 · Human Reproduction Update · 478 citations
https://doi.org/10.1093/humupd/dmu009
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial
2018 · Diabetologia · 121 citations
https://doi.org/10.1007/s00125-018-4644-9
Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome
2020 · Human Reproduction · 50 citations
https://doi.org/10.1093/humrep/deaa104
Bladder cancer in the EMPA-REG OUTCOME trial
2017 · Diabetologia · 31 citations
https://doi.org/10.1007/s00125-017-4430-0
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
2020 · Cardiovascular Diabetology · 29 citations
https://doi.org/10.1186/s12933-020-01174-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat